Terms: = Breast cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Diagnosis
7 results:
1. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
2. BC-DETECT: combined detection of serum he4 and TFF3 improves breast cancer diagnostic efficacy.
Abdelrazek MA; Nageb A; Barakat LA; Abouzid A; Elbaz R
Breast Cancer; 2022 May; 29(3):507-515. PubMed ID: 34994942
[TBL] [Abstract] [Full Text] [Related]
3. A strengthening the reporting of observational studies in epidemiology (STROBE): Are he4 and CA 125 suitable to detect a Paget disease of the vulva?
Dellino M; Gargano G; Tinelli R; Carriero C; Minoia C; Tetania S; Silvestris E; Loizzi V; Paradiso A; Casamassima P; Tufaro A; Cormio G; Garrisi VM
Medicine (Baltimore); 2021 Feb; 100(5):e24485. PubMed ID: 33592901
[TBL] [Abstract] [Full Text] [Related]
4. Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4.
Shen Y; Wang Y; Jiang X; Lu L; Wang C; Luo W; Zhang Y; Li P; Du Z; Dai T; Wu C; Fang A; Yao Y; Peng Q; Yang J
Protein Expr Purif; 2018 Jan; 141():44-51. PubMed ID: 28928083
[TBL] [Abstract] [Full Text] [Related]
5. Combined detection of plasma miR-127-3p and he4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract] [Full Text] [Related]
6. he4 in the differential diagnosis of a pelvic mass: a case report.
Anastasi E; Granato T; Coppa A; Manganaro L; Giannini G; Comploj S; Frati L; Midulla C
Int J Mol Sci; 2011 Jan; 12(1):627-32. PubMed ID: 21340004
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis of he4 expression in normal and malignant human tissues.
Galgano MT; Hampton GM; Frierson HF
Mod Pathol; 2006 Jun; 19(6):847-53. PubMed ID: 16607372
[TBL] [Abstract] [Full Text] [Related]
